InvestorsHub Logo
Followers 55
Posts 13542
Boards Moderated 0
Alias Born 10/12/2006

Re: PorscheTech post# 744

Thursday, 02/15/2018 7:18:36 PM

Thursday, February 15, 2018 7:18:36 PM

Post# of 3504
The only recent coverage I could find was from Dec 2017:

Roth Capital initiates coverage on Moleculin Biotech (NASDAQ: MBRX) with a Buy rating and a price target of $8.00.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MBRX News